Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

INTRODUCTION: suPAR is the soluble form of the urokinase plasminogen activator receptor (uPAR), which is expressed in various immunologically active cells. High suPAR serum concentrations are suggested to reflect the activation of the immune system in circumstances of inflammation and infection, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Koch, Alexander, Voigt, Sebastian, Kruschinski, Carsten, Sanson, Edouard, Dückers, Hanna, Horn, Andreas, Yagmur, Eray, Zimmermann, Henning, Trautwein, Christian, Tacke, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3221996/
https://ncbi.nlm.nih.gov/pubmed/21324198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc10037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados